02378oam 2200649zu 450 991069868340332120210807004703.0(CKB)3450000000002106(SSID)ssj0000621015(PQKBManifestationID)11926328(PQKBTitleCode)TC0000621015(PQKBWorkID)10613426(PQKB)10897833(WaSeSS)Innodata00029870(OCoLC)301351975(EXLCZ)99345000000000210620160829d2008 uy engur|||||||||||txtccrHER2 testing to manage patients with breast cancer or other solid tumors[Place of publication not identified]U S Dept of Health and Human Services Agency for Healthcare Research and Quality20081 online resourceEvidence report/technology assessment HER2 testing to manage patients with breast cancer or other solid tumorsBibliographic Level Mode of Issuance: MonographIncludes bibliographical references.Evidence report/technology assessment ;no. 172.AHRQ publication ;no. 09-E001.BreastCancerHER-2 geneCancerGene therapyBreastGenes, erbB-2geneticsNeoplasmsgeneticsAntibodies, Monoclonaltherapeutic useAntineoplastic Agentstherapeutic useGenetic TestingmethodsNeoplasmsdrug therapyReview.BreastCancerHER-2 geneCancerGene therapyBreastGenes, erbB-2genetics.Neoplasmsgenetics.Antibodies, Monoclonaltherapeutic use.Antineoplastic Agentstherapeutic use.Genetic Testingmethods.Neoplasmsdrug therapy.Seidenfeld JeromeBlue Cross and Blue Shield Association Technology Evaluation Center.United States Agency for Healthcare Research and QualityPQKBBOOK9910698683403321HER2 testing to manage patients with breast cancer or other solid tumors3177994UNINA